Different ventricular remodelling and autonomic modulation after long-term beta-blocker treatment in hypertensive, ischaemic and idiopathic dilated cardiomyopathy

Journal of Cardiovascular Medicine

Volumn 8, Issue 10, 2007, Pages 840-845

  Malfatto, Gabriella ^a,b   Branzi, Giovanna ^a   Ciambellotti, Francesca ^a   Valli, Paola ^a   Bizzi, Caterina ^a   Facchini, Mario ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b Ist Scientifico Ospedale San Luca   (Italy)

Author keywords

blockers; Autonomic modulation; Heart failure; Hypertension; Ventricular remodelling

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; LISINOPRIL; NITRATE; SPIRONOLACTONE;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG DOSE TITRATION; ECHOCARDIOGRAPHY; EXERCISE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LONG TERM CARE; SPECTROSCOPY; STATISTICAL SIGNIFICANCE;

ADRENERGIC BETA-ANTAGONISTS; AUTONOMIC NERVOUS SYSTEM; CARBAZOLES; CARDIOMYOPATHY, DILATED; HUMANS; HYPERTENSION; MIDDLE AGED; PROPANOLAMINES; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 34748857980     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328011708b     Document Type: Article

References (33)

1. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effects of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334:1349-1355.
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353:9-13.
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353:2001-2007.
4. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971; 285:877-883.
5. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-823.
6. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20:248-254.
7. Braunwald E. The Denolin lecture. Congestive heart failure: a half century perspective. Eur Heart J 2001; 22:825-836.
8. Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001; 21:661-672.
9. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-241.
10. Mortara A, La Rovere MT, Signorini MG, Pantaleo P, Pinna G, Martinelli L, et al. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J 1994; 71:422-430.
11. Guzzetti S, Cogliati C, Turiel M, Crema C, Lombardi F, Malliani A. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J 1995; 16:1100-1107.
12. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003; 107:565-570.
13. Mortara A, La Rovere MT, Pinna GD, Maestri R, Capomolla S, Cobelli F. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroreflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol 2000; 36:1612-1618.
14. Malfatto G, Facchini M, Branzi G, Riva B, Sala L, Perego GB. Long-term treatment with the beta-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure. J Cardiovasc Pharmacol 2003; 42:125-131.
15. Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J Am Coll Cardiol 1997; 29:1060-1066.
16. Capomolla S, Febo O, Gnemmi M, Riccardi G, Caporotondi A, Mortara A, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000; 139:596-608.
17. Rahko PS. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy. Echocardiography 2005; 22:547-554.
18. Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am Heart J 2003; 145:292-299.
19. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:1115-1140.
20. Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Naqvi TZ. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006; 19:955-972.
21. Pinna GD, Maestri R, La Rovere MT, Mortara A. An oscillation of the respiratory control system accounts for most of the heart period variability of chronic heart failure patients. Clin Sci (Lond) 1996; 91 (Suppl): 89-91.
22. Mortara A, Sleight P, Pinna GD, Maestri R, Prpa A, La Rovere MT, et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart variability. Circulation 1997; 96:246-252.
23. Malliani A. The pattern of sympathovagal balance explored in the frequency domain. News Physiol Sci 1999; 14:111-117.
24. Cooley RL, Montano N, Cogliati C, van de Borne P, Richenbacher W, Oren R, et al. Evidence for a central origin of the low-frequency oscillation in RR-interval variability. Circulation 1998; 98:556-561.
25. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006; 367:356-367.
26. Ohtsuka T, Hamada M, Saeki H, Ogimoto A, Hara Y, Shigematsu Y, et al. Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels. Am J Cardiol 2003; 91:1024-1027.
27. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000; 35:569-582.
28. Pagani M, Lombardi F, Guzzetti S, Sandrone G, Rimoldi O, Malfatto G, et al. Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects. J Hypertens Suppl 1984; 2:S383-S385.
29. Malliani A, Pagani M, Lombardi F, Furlan R, Guzzetti S, Cerutti S. Spectral analysis to assess increased sympathetic tone in arterial hypertension. Hypertension 1991; 17 (Suppl):III36-III42.
30. Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens 1998; 16 (Pt 2):1979-1987.
31. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bolla G, Mancia G. Effects of hypertension and obesity on the sympathetic activation of heart failure patients. Hypertension 2003; 42:873-877.
32. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351:478-484.
33. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004; 95:754-763.